Innocan Pharma (INNPF) Non-Current Assets (2024 - 2025)
Innocan Pharma (INNPF) recorded Non-Current Assets of $86,000 in the quarter ended Dec 31, 2025, down 23.9% from $113,000 a year earlier.
Powered by 
Analysis
Innocan Pharma (INNPF) Non-Current Assets (2024 - 2025) Analysis & Trends
- Across earlier years, Non-Current Assets came in at $113,000 in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 86,000.00 |
API Access
Innocan Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();